329 related articles for article (PubMed ID: 22069708)
21. Human CD18 is the functional receptor for Aggregatibacter actinomycetemcomitans leukotoxin.
Dileepan T; Kachlany SC; Balashova NV; Patel J; Maheswaran SK
Infect Immun; 2007 Oct; 75(10):4851-6. PubMed ID: 17635865
[TBL] [Abstract][Full Text] [Related]
22. The Extracellular Domain of the β
Ristow LC; Tran V; Schwartz KJ; Pankratz L; Mehle A; Sauer JD; Welch RA
mBio; 2019 Jul; 10(4):. PubMed ID: 31289186
[TBL] [Abstract][Full Text] [Related]
23. Absence of an especially toxic clone among isolates of Actinobacillus actinomycetemcomitans recovered from army recruits.
Macheleidt A; Müller HP; Eger T; Putzker M; Fuhrmann A; Zöller L
Clin Oral Investig; 1999 Dec; 3(4):161-7. PubMed ID: 10803129
[TBL] [Abstract][Full Text] [Related]
24. Epigallocatechin gallate alters leukotoxin secretion and Aggregatibacter actinomycetemcomitans virulence.
Chang EH; Brown AC
J Pharm Pharmacol; 2021 Mar; 73(4):505-514. PubMed ID: 33793838
[TBL] [Abstract][Full Text] [Related]
25. IL-1beta secretion induced by Aggregatibacter (Actinobacillus) actinomycetemcomitans is mainly caused by the leukotoxin.
Kelk P; Claesson R; Chen C; Sjöstedt A; Johansson A
Int J Med Microbiol; 2008 Jul; 298(5-6):529-41. PubMed ID: 17888725
[TBL] [Abstract][Full Text] [Related]
26. Aggregatibacter actinomycetemcomitans leukotoxin causes activation of lymphocyte function-associated antigen 1.
Nygren P; Balashova N; Brown AC; Kieba I; Dhingra A; Boesze-Battaglia K; Lally ET
Cell Microbiol; 2019 Mar; 21(3):e12967. PubMed ID: 30329215
[TBL] [Abstract][Full Text] [Related]
27. High salivary levels of JP2 genotype of Aggregatibacter actinomycetemcomitans is associated with clinical attachment loss in Moroccan adolescents.
Ennibi OK; Claesson R; Akkaoui S; Reddahi S; Kwamin F; Haubek D; Johansson A
Clin Exp Dent Res; 2019 Feb; 5(1):44-51. PubMed ID: 30847232
[TBL] [Abstract][Full Text] [Related]
28. TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans.
Crosby JA; Kachlany SC
Gene; 2007 Feb; 388(1-2):83-92. PubMed ID: 17116373
[TBL] [Abstract][Full Text] [Related]
29. Oral pathogenesis of Aggregatibacter actinomycetemcomitans.
Gholizadeh P; Pormohammad A; Eslami H; Shokouhi B; Fakhrzadeh V; Kafil HS
Microb Pathog; 2017 Dec; 113():303-311. PubMed ID: 29117508
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effect of synthetic histatin 5 on leukotoxin from Actinobacillus actinomycetemcomitans.
Murakami Y; Xu T; Helmerhorst EJ; Ori G; Troxler RF; Lally ET; Oppenheim FG
Oral Microbiol Immunol; 2002 Jun; 17(3):143-9. PubMed ID: 12030965
[TBL] [Abstract][Full Text] [Related]
31. Membrane localization of the Repeats-in-Toxin (RTX) Leukotoxin (LtxA) produced by Aggregatibacter actinomycetemcomitans.
Brown AC; Boesze-Battaglia K; Balashova NV; Mas Gómez N; Speicher K; Tang HY; Duszyk ME; Lally ET
PLoS One; 2018; 13(10):e0205871. PubMed ID: 30335797
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of P2X Receptors Protects Human Monocytes against Damage by Leukotoxin from Aggregatibacter actinomycetemcomitans and α-Hemolysin from Escherichia coli.
Fagerberg SK; Jakobsen MR; Skals M; Praetorius HA
Infect Immun; 2016 Nov; 84(11):3114-3130. PubMed ID: 27528275
[TBL] [Abstract][Full Text] [Related]
33. Release and activation of matrix metalloproteinase 8 from human neutrophils triggered by the leukotoxin of Actinobacillus actinomycetemcomitans.
Claesson R; Johansson A; Belibasakis G; Hänström L; Kalfas S
J Periodontal Res; 2002 Oct; 37(5):353-9. PubMed ID: 12366858
[TBL] [Abstract][Full Text] [Related]
34. Beyond the specific plaque hypothesis: are highly leukotoxic strains of Actinobacillus actinomycetemcomitans a paradigm for periodontal pathogenesis?
Guthmiller JM; Lally ET; Korostoff J
Crit Rev Oral Biol Med; 2001; 12(2):116-24. PubMed ID: 11345522
[TBL] [Abstract][Full Text] [Related]
35.
Velusamy SK; Sampathkumar V; Ramasubbu N; Paster BJ; Fine DH
Proc Natl Acad Sci U S A; 2019 Oct; 116(44):22307-22313. PubMed ID: 31611409
[No Abstract] [Full Text] [Related]
36. Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy.
Kachlany SC
J Dent Res; 2010 Jun; 89(6):561-70. PubMed ID: 20200418
[TBL] [Abstract][Full Text] [Related]
37. Abundant secretion of bioactive interleukin-1beta by human macrophages induced by Actinobacillus actinomycetemcomitans leukotoxin.
Kelk P; Claesson R; Hänström L; Lerner UH; Kalfas S; Johansson A
Infect Immun; 2005 Jan; 73(1):453-8. PubMed ID: 15618184
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Actinobacillus actinomycetemcomitans leukotoxicity by bacteria from the subgingival flora.
Johansson A; Hänström L; Kalfas S
Oral Microbiol Immunol; 2000 Aug; 15(4):218-25. PubMed ID: 11154406
[TBL] [Abstract][Full Text] [Related]
39. Serum-mediated release of leukotoxin from the cell surface of the periodontal pathogen Actinobacillus actinomycetemcomitans.
Johansson A; Claesson R; Hänström L; Kalfas S
Eur J Oral Sci; 2003 Jun; 111(3):209-15. PubMed ID: 12786951
[TBL] [Abstract][Full Text] [Related]
40. Profound Effects of Aggregatibacter actinomycetemcomitans Leukotoxin Mutation on Adherence Properties Are Clarified in in vitro Experiments.
Velusamy SK; Sampathkumar V; Godboley D; Fine DH
PLoS One; 2016; 11(3):e0151361. PubMed ID: 26977924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
